Advanced Medical Optics, Inc. (AMO) (NYSE: EYE), today announced it will
report third quarter 2008 financial results before the market opens on
Friday, October 31, 2008.
The company will host a conference call and live Webcast with investors
and analysts on Friday, October 31, 2008, at 10:00am EDT. To listen to
the live Webcast or to access the archived replay, please visit AMO’s
Investors page at http://www.amo-inc.com.
About Advanced Medical Optics (AMO)
AMO is focused on providing the full range of advanced refractive
technologies and support to help eye care professionals deliver optimal
vision and lifestyle experiences to patients of all ages. Products in
the cataract line include monofocal intraocular lenses (IOLs),
phacoemulsification systems, viscoelastics, and related products used in
ocular surgery. AMO owns or has the rights to such product brands as
Tecnis®, Clariflex®
and Sensar® IOLs; Sovereign®,
Sovereign® Compact and WhiteStar Signature™
phacoemulsification systems with WhiteStar®
technology; Healon® viscoelastics and the
Baerveldt® glaucoma shunt. Products in the
refractive line include wavefront diagnostic devices, femtosecond lasers
and associated patient interface devices; excimer laser vision
correction systems and treatment cards, and refractive implants. AMO
brands in the refractive business include iDesign™,
iFS™, Star S4 IR®,
WaveScan Wavefront®, Advanced CustomVue™,
IntraLase®, IntraLasik®
and ReZoom®, Tecnis®
Multifocal and Verisyse® IOLs. Products in
the eye care line include disinfecting solutions, enzymatic cleaners,
lens rewetting drops and artificial tears. Among the eye care product
brands the company possesses are COMPLETE®,
COMPLETE® Blink-N-Clean®,
Consept®F, Consept®
1 Step, Oxysept® 1 Step, UltraCare®,
Ultrazyme®, Total Care™
and blink® branded products. AMO is based in
Santa Ana, California, and employs approximately 4,000 worldwide. The
company has operations in 30 countries and markets products in
approximately 60 countries. For more information, visit the company's
Website at www.amo-inc.com.